Redefining Pituitary Neuroendocrine Tumors in MEN1: Prevalence, Clinical Behavior, and Implications for Long-Term Surveillance.

Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE).

Mixed gangliocytoma-pituitary neuroendocrine tumour: clinical, immunohistochemical, and molecular genetic profiles in a series of four patients.

Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas.

Clinical and radiological features of Rathke's cleft cysts with inflammatory change: Multivariable analysis of 262 surgically treated cases.

Brain injury biomarkers and intraoperative hypotension: associations with pituitary hormone deficiency following transsphenoidal endoscopic surgery for non-functioning pituitary adenomas.

Acromegaly and breast cancer risk: evidence from a systematic review and meta-analysis.

Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatment.

Prospectively assessed hypothalamic-pituitary dysfunction after proton therapy in adults with head and neck, skull base and brain tumors.

Comprehensive Comparison of Visual Outcomes in Macro and Giant Prolactinoma Cohorts Managed With Medical Versus Surgical Treatment.

Epidemiologic Profile and Clinical Outcomes of Adult Patients with Prolactinoma at the Philippine General Hospital.

Minimally Invasive Cyst Drainage for Cystic Craniopharyngioma: Neuroendoscopic Fenestration or Stereotactic Cyst Drainage?

Endoscopic endonasal surgery using indocyanine green fluorescence endoscope for Cushing's disease caused by mixed intrasellar gangliocytoma and adrenocorticotropin adenoma: illustrative case.

Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly.

Prevalence, risk factors, and impacts of sleep disturbances in patients with primary brain tumors: a systematic review.

Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): Pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant.

The oxytocin system in patients with craniopharyngioma: A systematic review.

Fugitive Acromegaly: A Historical, Clinical, and Translational Perspective.

GH-Secreting Adenoma or Tumor? Issues in Pituitary Neoplasms Nomenclature, Classification, and Characterization.

Mixed Gangliocytoma-Pituitary Adenoma: A Systematic Review of Diagnostic Features, Clinical Management, and Surgical Outcomes.

B2R-D2R Interaction in Prolactinomas and Nonfunctional Adenomas: Impact on Dopamine Resistance.

Deleterious effects of social isolation on neuroendocrine-immune status, and cancer progression in rats.

A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomas.

[Clinical case of plurihormonal pituitary adenoma (STH/ACTH/TSH/FSH/LH-secreting), diagnostic pitfalls].

Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas-A Pilot Study.

Mixed pituitary adenoma/pituitary neuroendocrine tumor-gangliocytoma: Immunohistochemical insights.

Shaping the curve from the microscopic transsphenoidal to the endoscopic endonasal approach for the sellar region.

Endoscopic endonasal transsphenoidal approach improves endocrine function and surgical outcome in primary craniopharyngioma resection: a systematic review and meta-analysis.

Complete Shrinking of Mixed Growth Hormone and Prolactin-Secreting Pituitary Adenoma With Bromocriptine Therapy Alone.

Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.

The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.

Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives.

Enhanced outcomes in residual or recurrent craniopharyngioma: evaluating combined gamma knife and phosphorus-32 brachytherapy.

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases.

Clinical Characteristics of Childhood-Onset Craniopharyngioma.

Clinical Characteristics, Diagnosis, and Treatment of Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor (TSH PitNET): A Single-Center Experience.

PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas.

The Value of ER∝ in the Prognosis of GH- and PRL-Secreting PitNETs: Clinicopathological Correlations.

Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature.

Determination of PDK1, SLC2A1, EGFR, PTEN, CD276 Gene Expression Levels and IDH1 Gene R132H Polymorphism in Brain Tumor Tissues.

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.

Altered hemispheric asymmetry of attentional networks in patients with pituitary adenoma: an event-related potential study.

Refractory Pit1 plurihormonal tumours and thyrotroph adenomas.

Social determinants of cognitive outcomes in survivors of pediatric brain tumors treated with conformal radiation therapy.

Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only.

A rare pituitary tumor associated with hyperthyroidism and acromegaly.

[New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly.

Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy.

Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma.

Pathological and Prognostic Characterization of Craniopharyngioma Based on the Expression of TrkA, β-Catenin, Cell Cycle Markers, and BRAF V600E Mutation.

Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Osilodrostat oral tablets for adults with Cushing's disease.

Mixed gangliocytoma-pituitary adenoma in MEN1 syndrome: A case report and literature review.

Equivalent outcomes in nasal symptoms following microscopic or endoscopic transsphenoidal surgery: results from multi-centre, prospective study.

Gamma knife radiosurgery in pituitary adenomas. A single-center experience.

Novel Classification of Acromegaly in Accordance with Immunohistochemical Subtypes: Is There Really a Clinical Relevance?

Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.

Sleep disturbances in craniopharyngioma: a challenging diagnosis.

Multiple roles for peptidylglycine α-amidating monooxygenase in the response to hypoxia.

Altered endocannabinoid-dynamics in craniopharyngioma patients and their association with HPA-axis disturbances.

A Potential Concomitant Sellar Embryonic Remnant-Associated Collision Tumor: Systematic Review.

PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours.

The impact of socioeconomic status (SES) on cognitive outcomes following radiotherapy for pediatric brain tumors: a prospective, longitudinal trial.

Primary intrasellar schwannoma with intratumoral hemorrhage mimicking pituitary apoplexy: A case report.

Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain.

Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly.

Pediatric pituitary adenoma with mixed FSH and TSH immunostaining and FSH hypersecretion in a 6 year-old girl with precocious puberty: case report and multidisciplinary management.

Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".

Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.

Prior smoking and nasoseptal flap usage adversely impact quality of life and healing after endoscopic pituitary surgery.

Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions.

Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.

Adult craniopharyngioma: The role of extent of resection in tumor recurrence and long-term functional outcome.

Patients with true mixed growth hormone and prolactin-secreting pituitary adenoma: a case series of 12 patients.

10 Years' Experience of Using Low-Field Intraoperative MRI in Transsphenoidal Surgery for Pituitary Adenoma: Results of the Swiss Pituitary Registry (SwissPit).

A Novel, Hybrid, Stereotactic Approach (Radiosurgery and Dual Ommaya Reservoirs) for the Treatment of Mixed (Polycystic and Solid) Craniopharyngioma.

Functioning Pituitary Adenoma with Xanthogranulomatous Features: Review of Literature and Case Report.

Sellar/Suprasellar Ganglioglioma: Clinical Image.

Comprehensive Evaluation of Rare Pituitary Lesions: A Single Tertiary Care Pituitary Center Experience and Review of the Literature.

Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances.

Primary tumors of the posterior pituitary: A systematic review.

Ex Vivo 1H NMR study of pituitary adenomas to differentiate various immunohistochemical subtypes.

PGAM5-CypD pathway is involved in bromocriptine-induced RIP3/MLKL-dependent necroptosis of prolactinoma cells.

Pediatric pituitary adenomas in Northeast Mexico. A follow-up study.

Predicting parental distress among children newly diagnosed with craniopharyngioma.

Pituitary adenomas in children and young adults.

Epidemiology and biomarker profile of pituitary adenohypophysial tumors.

A prospective longitudinal study of Pasireotide in Nelson's syndrome.

Silent somatotroph pituitary adenomas: an update.

HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis.

Editor's Highlight: Structure-Based Investigation on the Binding and Activation of Typical Pesticides With Thyroid Receptor.

Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.

Adrenal Cushing's syndrome during pregnancy.

An FSH and TSH pituitary adenoma, presenting with precocious puberty and central hyperthyroidism.

X-LAG: How did they grow so tall?

Epigenetic Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related Pathogenesis and Current Challenges in Biomarker Development.

High Ki-67 expression is associated with prolactin secreting pituitary adenomas.

Screening for genetic causes of growth hormone hypersecretion.

A Case of Mixed Germ Cell Tumor in the Intramedullary Spinal-cord.

Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas.

TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.

In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells.

Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells.

Three-dimensional Alginate-bead Culture of Human Pituitary Adenoma Cells.

[Misleading diagnosis of hyperprolactinemia in women].

Unicystic Ameloblastomatoid Cystic Craniopharyngioma: Pathological Discussion and Clinical Significance of Cyst Formation in Adamantinomatous Craniopharyngioma.

GHRH excess and blockade in X-LAG syndrome.

Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.

Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children.

GHRH Receptor Expression in Malignant Mixed Müllerian Tumors: A Potentially Targetable Biopredictor.

Ganglion cell tumours in the sella turcica in close morphological connection with pituitary adenomas.

Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism.

Sellar gangliocytoma with adrenocorticotropic and prolactin adenoma.

Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.

Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study.

Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas.

A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.